Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · MESA LABORATORIES INC /CO/ (MLAB)

Mesa Labs Q1 revenue up 1.0%, operating income up 129%, net income down 40.3%

Mixed Impact 3 of 5 earnings Written later

Mesa Laboratories reported results for the quarter ended June 30, 2026, its fiscal first quarter of 2027. Revenue rose 1.0% to $60.1 million and operating income rose 129% to $7.0 million, but net income fell 40.3% to $2.8 million, or $0.49 per diluted share, because of nonoperating expense compared with nonoperating income in the prior-year period. Full-year guidance is due in November with first-half results.

Key points

  • Revenue was $60.1 million, up 1.0%; core organic revenue growth was 0.4%.
  • Operating income rose 129% to $7.0 million; net income fell 40.3% to $2.8 million, or $0.49 per diluted share.
  • Adjusted operating income excluding unusual items rose 19.5% to $15.4 million, or 25.6% of revenue.
  • The company repaid $8.7 million of debt and reported a Total Net Leverage Ratio of 1.85, below its 2.0 target.

The filing

CompanyMESA LABORATORIES INC /CO/ (MLAB)
Form8-K, current report
Filed with the SECAug 10, 2026, 4:03 PM ET
Accession number0001437749-26-026769

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.